Infineon Technologies AGIAUC100N10S5N040ATMA1MOSFETs

100V, N-Ch, 4 mΩ max, Automotive MOSFET, SS08 (5x6), OptiMOS™-5

Reducing CO2 emissions of passenger cars is accelerating the 48V board net adoption. For this emerging 48V market Infineon offers a broad portfolio of Automotive 80V and 100V MOSFETs, that are offered in different package types like TOLL (HSOF-8), TOLG (HSOG-8) and SSO8 (TDSON-8).
Additionally the 80V and 100V MOSFETs are offering the perfect selection for fuel injection as well as in-vehicle wireless charging applications.

Summary of Features

• RDS(on) down to 3.1 mOhm (80 V) and 4.0 mOhm (100 V) in SSO8 package
• Higher RDS(on) variants in 80 V and 100 V in small S3O8 package

 

Benefits

 

• Reduced conduction losses
• Optimized switching performance
• Reduced form factor compared to traditional SMD packages

 

Target Applications

 

• 48 V-12 V DC-DC converters
• 48 V battery management systems and power distribution
• 48 V e-booster, e-compressor and e-suspension
• 48 V auxiliaries

 

Related Article

 

OptiMOSTM-5 80 V/100 V automotive MOSFET in SSO8 and S3O8 packages for 48 V applications

See More New Products From Infineon

Discover More Solutions From Infineon

1,500 parts: Ships tomorrow

    Total$2.79Price for 1

    • Service Fee  $7.00

      Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2508+
      Manufacturer Lead Time:
      26 weeks
      Minimum Of :
      1
      Maximum Of:
      1500
      Country Of origin:
      Austria
         
      • Price: $2.7857
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2508+
      Manufacturer Lead Time:
      26 weeks
      Country Of origin:
      Austria
      • In Stock: 1,500 parts
      • Price: $2.7857

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.